Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ROGERS CORPROG · Entity 4438 | Director | February 22, 2017 | February 24, 2017 |
| Veritiv CorpVRTV · Entity 107723 | Director | April 24, 2019 | April 26, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ROGERS CORP
Report date February 22, 2017 · Filed February 24, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Capital (Common) StockSEC Table I · non-derivative | Direct | 2,915 |
Ending reported balance
After 2017-02-23 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2017-02-22 · Sale · Disposed 600 · Balance 5,415 Row 2 · 2017-02-22 · Sale · Disposed 700 · Balance 4,715 Row 3 · 2017-02-23 · Sale · Disposed 1,800 · Balance 2,915 |
Veritiv Corp
Report date April 24, 2019 · Filed April 26, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 11,773 |
Reported balance
After 2019-04-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-04-24 · Grant · Acquired 4,946 · Balance 11,773 F1: Each share of phantom stock is the economic equivalent of one share of Veritiv Corporation common stock. F2: Shares of phantom stock are fully vested and non-forfeitable on the grant date and shall be paid to the reporting person in shares of Veritiv Corporation common stock on the elected distribution date under the Veritiv Corporation Deferred Compensation Savings Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of phantom stock is the economic equivalent of one share of Veritiv Corporation common stock.
F2: Shares of phantom stock are fully vested and non-forfeitable on the grant date and shall be paid to the reporting person in shares of Veritiv Corporation common stock on the elected distribution date under the Veritiv Corporation Deferred Compensation Savings Plan.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
H.I.G. Acquisition Corp.
Report date November 01, 2022 · Filed November 02, 2022
Section 16 reporting ended · disclosed 2022-11-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B ordinary sharesSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-11-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-11-01 · Disposition to issuer · Disposed 35,000 · Balance 0 F1: The Class B ordinary shares ("Class B Shares") would have automatically converted into Class A ordinary shares of the Issuer at the time of the Issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, with no expiration date. F2: This Form 4 reflects the surrender to the Issuer of 35,000 Class B Shares for no consideration by the Reporting Person pursuant to the Share Surrender Letter, dated November 1, 2022, by and between the Issuer and the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: The Class B ordinary shares ("Class B Shares") would have automatically converted into Class A ordinary shares of the Issuer at the time of the Issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, with no expiration date.
F2: This Form 4 reflects the surrender to the Issuer of 35,000 Class B Shares for no consideration by the Reporting Person pursuant to the Share Surrender Letter, dated November 1, 2022, by and between the Issuer and the Reporting Person.
HUMANA INC
Report date April 18, 2019 · Filed April 19, 2019
Section 16 reporting ended · disclosed 2019-04-19. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Humana CommonSEC Table I · non-derivative | Direct | 688 |
Reported balance
Holding disclosure · report date 2019-04-18 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 688 F3: Includes 588 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under the Company's 2011 Plan of which 100% is vesting on 12/31/19. |
| Stock UnitSEC Table II · derivative / convertible security | Direct | 24,224 |
Reported balance
Holding disclosure · report date 2019-04-18 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 24,224 F1: Annual Director's fee payable in stock units which have been deferred at the election of the reporting person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1) and the total includes the vested portion that was subsequently deferred for years 2013 and later. |
| Stock UnitSEC Table II · derivative / convertible security | Direct | 1,008 |
Reported balance
Holding disclosure · report date 2019-04-18 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 1,008 F2: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). |
Filing footnotes · ownership attribution and instrument terms
F1: Annual Director's fee payable in stock units which have been deferred at the election of the reporting person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1) and the total includes the vested portion that was subsequently deferred for years 2013 and later.
F2: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).
F3: Includes 588 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under the Company's 2011 Plan of which 100% is vesting on 12/31/19.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 01, 2022 Filed Nov 2, 2022 06:30 UTC | H.I.G. Acquisition Corp. HIGA · Entity 122658 | Disposition to issuerClass B ordinary shares · Derivative | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-034725 · doc4.xml · derivative · entry 1 MITCHELL WILLIAM · CIK 0001187421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A ordinary shares · 35,000 shares Expires not disclosed F1 · derivative.exercise_price: The Class B ordinary shares ("Class B Shares") would have automatically converted into Class A ordinary shares of the Issuer at the time of the Issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, with no expiration date. F2 · price: This Form 4 reflects the surrender to the Issuer of 35,000 Class B Shares for no consideration by the Reporting Person pursuant to the Share Surrender Letter, dated November 1, 2022, by and between the Issuer and the Reporting Person. F1 · derivative.exercise_date: The Class B ordinary shares ("Class B Shares") would have automatically converted into Class A ordinary shares of the Issuer at the time of the Issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, with no expiration date. F1 · derivative.expiration_date: The Class B ordinary shares ("Class B Shares") would have automatically converted into Class A ordinary shares of the Issuer at the time of the Issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, with no expiration date. Read SEC document |
| April 24, 2019 Filed Apr 26, 2019 16:14 UTC | Veritiv Corp VRTV · Entity 107723 | GrantPhantom Stock · Derivative | 4,946 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-19-001009 · primary_01.xml · derivative · entry 1 MITCHELL WILLIAM · CIK 0001187421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,773 Underlying: Common Stock · 4,946 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Veritiv Corporation common stock. F2 · derivative.exercise_date: Shares of phantom stock are fully vested and non-forfeitable on the grant date and shall be paid to the reporting person in shares of Veritiv Corporation common stock on the elected distribution date under the Veritiv Corporation Deferred Compensation Savings Plan. F2 · derivative.expiration_date: Shares of phantom stock are fully vested and non-forfeitable on the grant date and shall be paid to the reporting person in shares of Veritiv Corporation common stock on the elected distribution date under the Veritiv Corporation Deferred Compensation Savings Plan. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 21:56 UTC | HUMANA INC HUM · Entity 1429 | GrantHumana Common | 588 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-19-000008 · edgar.xml · nonDerivative · entry 1 MITCHELL WILLIAM · CIK 0001187421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 688 F3 · balance_after: Includes 588 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under the Company's 2011 Plan of which 100% is vesting on 12/31/19. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 21:56 UTC | HUMANA INC HUM · Entity 1429 | GrantStock Unit · Derivative | 114 | $284.57 | $32,440.41 |
DisclosureSEC source: 0000049071-19-000008 · edgar.xml · derivative · entry 3 MITCHELL WILLIAM · CIK 0001187421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,008 Underlying: Humana Common · 114 shares Expires not disclosed F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| April 25, 2018 Filed Apr 26, 2018 17:09 UTC | Veritiv Corp VRTV · Entity 107723 | GrantPhantom Stock · Derivative | 3,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-18-000696 · primary_01.xml · derivative · entry 1 MITCHELL WILLIAM · CIK 0001187421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,827 Underlying: Common Stock · 3,674 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Veritiv Corporation common stock. F2 · derivative.exercise_date: Shares of phantom stock are fully vested and non-forfeitable on the grant date and shall be paid to the reporting person in shares of Veritiv Corporation common stock on the elected distribution date under the Veritiv Corporation Deferred Compensation Savings Plan. F2 · derivative.expiration_date: Shares of phantom stock are fully vested and non-forfeitable on the grant date and shall be paid to the reporting person in shares of Veritiv Corporation common stock on the elected distribution date under the Veritiv Corporation Deferred Compensation Savings Plan. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 21:11 UTC | HUMANA INC HUM · Entity 1429 | GrantStock Unit · Derivative | 105 | $249.45 | $26,192.25 |
DisclosureSEC source: 0000049071-18-000010 · edgar.xml · derivative · entry 3 MITCHELL WILLIAM · CIK 0001187421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 894 Underlying: Humana Common · 105 shares Expires not disclosed F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| May 25, 2017 Filed May 25, 2017 17:57 UTC | Veritiv Corp VRTV · Entity 107723 | GrantPhantom Stock · Derivative | 3,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-17-000738 · primary_01.xml · derivative · entry 1 MITCHELL WILLIAM · CIK 0001187421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,153 Underlying: Common Stock · 3,153 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Veritiv Corporation common stock. F2 · derivative.exercise_date: Shares of phantom stock are fully vested and non-forfeitable on the grant date and shall be paid to the reporting person in shares of Veritiv Corporation common stock on the elected distribution date under the Veritiv Corporation Deferred Compensation Savings Plan. F2 · derivative.expiration_date: Shares of phantom stock are fully vested and non-forfeitable on the grant date and shall be paid to the reporting person in shares of Veritiv Corporation common stock on the elected distribution date under the Veritiv Corporation Deferred Compensation Savings Plan. Read SEC document |
| February 23, 2017 Filed Feb 24, 2017 23:22 UTC | ROGERS CORP ROG · Entity 4438 | SaleCapital (Common) Stock | 1,800 | $89.20 | $160,560.00 |
DisclosureSEC source: 0001225208-17-004616 · doc4.xml · nonDerivative · entry 3 MITCHELL WILLIAM · CIK 0001187421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,915 Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 23:22 UTC | ROGERS CORP ROG · Entity 4438 | SaleCapital (Common) Stock | 700 | $88.78 | $62,147.33 |
DisclosureSEC source: 0001225208-17-004616 · doc4.xml · nonDerivative · entry 2 MITCHELL WILLIAM · CIK 0001187421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,715 Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 23:22 UTC | ROGERS CORP ROG · Entity 4438 | SaleCapital (Common) Stock | 600 | $88.78 | $53,268.90 |
DisclosureSEC source: 0001225208-17-004616 · doc4.xml · nonDerivative · entry 1 MITCHELL WILLIAM · CIK 0001187421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,415 Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 21:45 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 761 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000007 · edgar.xml · derivative · entry 4 MITCHELL WILLIAM · CIK 0001187421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 761 Underlying: Humana Common · 761 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017. Read SEC document |
| January 02, 2017 Filed Jan 3, 2018 21:11 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 658 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-18-000010 · edgar.xml · derivative · entry 4 MITCHELL WILLIAM · CIK 0001187421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 658 Underlying: Humana Common · 658 shares Expires not disclosed F3 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2018. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2018. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2018. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2018. Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 21:45 UTC | HUMANA INC HUM · Entity 1429 | GrantStock Unit · Derivative | 91 | $203.53 | $18,521.23 |
DisclosureSEC source: 0000049071-17-000007 · edgar.xml · derivative · entry 3 MITCHELL WILLIAM · CIK 0001187421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 789 Underlying: Humana Common · 91 shares Expires not disclosed F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| November 08, 2016 Filed Nov 10, 2016 21:37 UTC | ROGERS CORP ROG · Entity 4438 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 656 | $0.00 Strike: $40.45 | $0.00 |
DisclosureSEC source: 0001140361-16-085849 · doc1.xml · derivative · entry 6 MITCHELL WILLIAM · CIK 0001187421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Capital (Common) Stock · 656 shares Expires 2018-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2016 Filed Nov 10, 2016 21:37 UTC | ROGERS CORP ROG · Entity 4438 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,443 | $0.00 Strike: $46.87 | $0.00 |
DisclosureSEC source: 0001140361-16-085849 · doc1.xml · derivative · entry 5 MITCHELL WILLIAM · CIK 0001187421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Capital (Common) Stock · 1,443 shares Expires 2017-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2016 Filed Nov 10, 2016 21:37 UTC | ROGERS CORP ROG · Entity 4438 | SaleCapital (Common) Stock | 656 | $69.04 | $45,293.39 |
DisclosureSEC source: 0001140361-16-085849 · doc1.xml · nonDerivative · entry 4 MITCHELL WILLIAM · CIK 0001187421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,015 F2 · price: Represents the weighted average price of sales at prices that ranged from $69.0396 to $69.10. The Reporting Person will provide the full details to the SEC, the Issuer, or any shareholder of the Issuer upon request. Read SEC document |
| November 08, 2016 Filed Nov 10, 2016 21:37 UTC | ROGERS CORP ROG · Entity 4438 | SaleCapital (Common) Stock | 1,443 | $69.02 | $99,599.90 |
DisclosureSEC source: 0001140361-16-085849 · doc1.xml · nonDerivative · entry 3 MITCHELL WILLIAM · CIK 0001187421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,671 F1 · price: Represents the weighted average price of sales at prices that ranged from $68.98 to $69.10. The Reporting Person will provide the full details to the SEC, the Issuer, or any shareholder of the Issuer upon request. Read SEC document |
| November 08, 2016 Filed Nov 10, 2016 21:37 UTC | ROGERS CORP ROG · Entity 4438 | Exercise / conversionCapital (Common) Stock | 656 | $40.45 | $26,535.20 |
DisclosureSEC source: 0001140361-16-085849 · doc1.xml · nonDerivative · entry 2 MITCHELL WILLIAM · CIK 0001187421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,114 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2016 Filed Nov 10, 2016 21:37 UTC | ROGERS CORP ROG · Entity 4438 | Exercise / conversionCapital (Common) Stock | 1,443 | $46.87 | $67,633.41 |
DisclosureSEC source: 0001140361-16-085849 · doc1.xml · nonDerivative · entry 1 MITCHELL WILLIAM · CIK 0001187421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,458 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2016 Filed Nov 8, 2016 21:12 UTC | ROGERS CORP ROG · Entity 4438 | SaleCapital (Common) Stock | 3,000 | $68.58 | $205,730.10 |
DisclosureSEC source: 0001140361-16-085405 · doc1.xml · nonDerivative · entry 1 MITCHELL WILLIAM · CIK 0001187421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,015 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.